Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-36
Closed -$4K 97
2020
Q3
$4K Hold
36
﹤0.01% 386
2020
Q2
$4K Buy
+36
New +$3.22K ﹤0.01% 393
2019
Q2
Sell
-576
Closed -$17K 418
2019
Q1
$17K Hold
576
0.01% 348
2018
Q4
$17K Buy
+576
New +$18.3K 0.01% 331
2016
Q4
Sell
-620
Closed -$14K 421
2016
Q3
$14K Hold
620
0.01% 385
2016
Q2
$12K Sell
620
-1,000
-62% -$17K 0.01% 373
2016
Q1
$28K Sell
1,620
-20,160
-93% -$337K 0.02% 352
2015
Q4
$446K Buy
+21,780
New +$453K 0.33% 61
2015
Q2
Sell
-652
Closed -$10K 434
2015
Q1
$10K Hold
652
0.01% 397
2014
Q4
$9K Buy
+652
New +$7.98K 0.01% 382
2014
Q2
Sell
-42,720
Closed -$442K 404
2014
Q1
$442K Buy
+42,720
New +$442K 0.31% 143

Other funds holding DXCM

Alpha Windward's DXCM Position: Q4 2020 in Review

Alpha Windward sold out of DexCom (DXCM) in Q4 2020, closing a stake of 36 shares — an estimated $4K sold.

Alpha Windward first reported a position in DXCM in Q1 2014 and held it in 11 quarters. The position peaked at $446K in Q4 2015. 732 funds tracked by Wall St. Rank hold DXCM as of Q4 2020.

  • Alpha Windward reported no remaining DexCom position as of Q4 2020 after selling out during the quarter.
  • Alpha Windward sold 36 DexCom shares in Q4 2020, an estimated $4K.
  • Alpha Windward first reported a position in DexCom in Q1 2014 and held it in 11 quarters.
  • Alpha Windward's DexCom position peaked at $446K in Q4 2015.
  • 732 funds tracked by Wall St. Rank held DexCom as of Q4 2020.

Based on Alpha Windward's 13F filing for Q4 2020.